Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty

PURPOSE: Long-acting gonadotropin-releasing hormone agonists (GnRHa) are commonly used to treat central precocious puberty (CPP) in Korea. Although rare, there have been reports on the characteristic of adverse reactions of GnRHa in CPP among the Korean population. This study was intended to report...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Woo, Kim, Hyung Jin, Choe, Yun Mee, Kang, Hee Suk, Kim, Soon Ki, Jun, Yong Hoon, Lee, Ji Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Endocrinology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208261/
https://www.ncbi.nlm.nih.gov/pubmed/25346917
http://dx.doi.org/10.6065/apem.2014.19.3.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208261/
https://www.ncbi.nlm.nih.gov/pubmed/25346917
http://dx.doi.org/10.6065/apem.2014.19.3.135

Ejemplares similares